Reconstituted botulinum type A neurotoxin: Clinical efficacy after long-term freezing before use

Aesthetic Plastic Surgery

Volumn 31, Issue 2, 2007, Pages 188-191

  Parsa, Alan A ^a   Lye, Kevin D ^b   Parsa, Fereydoun Don ^b  

^a SETON HALL UNIVERSITY   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

Botox; Botulinum neurotoxin; Effectiveness of Botox; Freezing preservation of Botox; Long term storage of Botox; Side effects of Botox

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG POTENCY; DRUG STABILITY; FEMALE; FLU LIKE SYNDROME; FREEZING; HUMAN; INJECTION SITE PARESTHESIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REJUVENATION;

ADULT; AGED; BOTULINUM TOXIN TYPE A; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION; DRUG PACKAGING; DRUG STORAGE; FEMALE; FREEZE DRYING; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; RHYTIDOPLASTY; TREATMENT OUTCOME;

EID: 34247277567     PISSN: 0364216X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00266-006-0161-1     Document Type: Article

References (13)

1. Allergan, Inc: Botox cosmetic (botulinum toxin type A) purified neurotoxin complex [package insert]. Allergan, Inc., Irvine, CA, USA
2. Arthurs B, Flanders M, Codere F, Gauthier S, Dresner S, Stone L: Treatment of blepharospasm with medication, surgery, and type A botulinum toxin. Can J Ophthalmol 22:24-28, 1987
3. Fagien S: Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: Adjunctive use in facial aesthetic surgery. Plast Reconstr Surg 112:40s-52s, 2003
4. Freeman A (principal investigator): A randomized, multicenter, double-blind, placebo-controlled study of intramuscular BOTOX (botulinum toxin type A) purified neurotoxin complex for the treatment of cervical dystonia. Data on file. Allergan, Inc., Irvine, CA, USA, June 1995-June 1998
5. Guerrissi JO: Intraoperative injection of botulinum toxin A into the orbicularis oculi muscle for the treatment of crow's feet. Plast Reconstr Surg 112:161s-163s, 2003
6. Kim EJ, Ramirez AL, Reeck JB, Maas CS: The role of botulinum type B (Myobloc) in the treatment of hyperkinetic facial lines. Plast Reconst Surg 112:88s-93s, 2003
7. Koriazova LK, Montal M: Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nat Struct Biol 10:13-18, 2003
8. Niamtu J: Cosmetic oral and maxillofacial surgery options. J Am Dent Assoc 131:756-764, 2000
9. Parsa FD: How to avoid eyelid ptosis when injecting botulinum toxin into the corrugators. Plast Reconstr Surg 105:1564-1565, 2000
10. Preacher KJ, Briggs NE. Calculation for Fisher's exact test: An interactive calculation tool for Fisher's exact probability test for 2 x 2 tables (computer software). Accessed 25 July 2006 at http://www.unc.edu/ ∼preacher/fisher/fisher.htm
11. Rohrich RJ, Janis JE, Fagien S, Stuzin JM: The cosmetic use of botulinum toxin. Plast Reconstr Surg 112:177s-187s, 2003
12. Singh BR: Critical aspects of bacterial protein toxins. Adv Exp Med Biol 391:63-84, 1996
13. 6-tagged recombinant type B botulinum neurotoxin heavy chain transmembrane and binding domain. Protein Expr Purif 34:8-16, 2004